These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 30931980)

  • 21. Prostaglandin E2 regulates its own inactivating enzyme, 15-PGDH, by EP2 receptor-mediated cervical cell-specific mechanisms.
    Kishore AH; Owens D; Word RA
    J Clin Endocrinol Metab; 2014 Mar; 99(3):1006-18. PubMed ID: 24471568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of ginger root on cyclooxygenase-1 and 15-hydroxyprostaglandin dehydrogenase expression in colonic mucosa of humans at normal and increased risk for colorectal cancer.
    Jiang Y; Turgeon DK; Wright BD; Sidahmed E; Ruffin MT; Brenner DE; Sen A; Zick SM
    Eur J Cancer Prev; 2013 Sep; 22(5):455-60. PubMed ID: 23222413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers.
    Yan M; Rerko RM; Platzer P; Dawson D; Willis J; Tong M; Lawrence E; Lutterbaugh J; Lu S; Willson JK; Luo G; Hensold J; Tai HH; Wilson K; Markowitz SD
    Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17468-73. PubMed ID: 15574495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs).
    Tai HH; Chi X; Tong M
    Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):37-40. PubMed ID: 21763448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-aminosalicylic acid mediates expression of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase to suppress colorectal tumorigenesis.
    Miyoshi J; Yajima T; Shimamura K; Matsuoka K; Okamoto S; Higuchi H; Funakoshi S; Takaishi H; Hibi T
    Anticancer Res; 2012 Apr; 32(4):1193-202. PubMed ID: 22493349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-182 promotes cell growth and invasion by targeting forkhead box F2 transcription factor in colorectal cancer.
    Zhang Y; Wang X; Wang Z; Tang H; Fan H; Guo Q
    Oncol Rep; 2015 May; 33(5):2592-8. PubMed ID: 25738520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repression of 15-hydroxyprostaglandin dehydrogenase involves histone deacetylase 2 and snail in colorectal cancer.
    Backlund MG; Mann JR; Holla VR; Shi Q; Daikoku T; Dey SK; DuBois RN
    Cancer Res; 2008 Nov; 68(22):9331-7. PubMed ID: 19010907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD).
    Fink SP; Yamauchi M; Nishihara R; Jung S; Kuchiba A; Wu K; Cho E; Giovannucci E; Fuchs CS; Ogino S; Markowitz SD; Chan AT
    Sci Transl Med; 2014 Apr; 6(233):233re2. PubMed ID: 24760190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-21 regulates prostaglandin E2 signaling pathway by targeting 15-hydroxyprostaglandin dehydrogenase in tongue squamous cell carcinoma.
    He Q; Chen Z; Dong Q; Zhang L; Chen D; Patel A; Koya A; Luan X; Cabay RJ; Dai Y; Wang A; Zhou X
    BMC Cancer; 2016 Aug; 16(1):685. PubMed ID: 27561985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiRNA-206 suppresses PGE2-induced colorectal cancer cell proliferation, migration, and invasion by targetting TM4SF1.
    Park YR; Seo SY; Kim SL; Zhu SM; Chun S; Oh JM; Lee MR; Kim SH; Kim IH; Lee SO; Lee ST; Kim SW
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30135139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bile acids inhibit NAD+-dependent 15-hydroxyprostaglandin dehydrogenase transcription in colonocytes.
    Miyaki A; Yang P; Tai HH; Subbaramaiah K; Dannenberg AJ
    Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G559-66. PubMed ID: 19608733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-620 promotes tumor radioresistance by targeting 15-hydroxyprostaglandin dehydrogenase (HPGD).
    Huang X; Taeb S; Jahangiri S; Korpela E; Cadonic I; Yu N; Krylov SN; Fokas E; Boutros PC; Liu SK
    Oncotarget; 2015 Sep; 6(26):22439-51. PubMed ID: 26068950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impacts of cytosolic phospholipase A2, 15-prostaglandin dehydrogenase, and cyclooxygenase-2 expressions on tumor progression in colorectal cancer.
    Lim SC; Cho H; Lee TB; Choi CH; Min YD; Kim SS; Kim KJ
    Yonsei Med J; 2010 Sep; 51(5):692-9. PubMed ID: 20635443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HSP90 Inhibition Suppresses PGE2 Production via Modulating COX-2 and 15-PGDH Expression in HT-29 Colorectal Cancer Cells.
    Mohammadi A; Yaghoobi MM; Gholamhoseinian Najar A; Kalantari-Khandani B; Sharifi H; Saravani M
    Inflammation; 2016 Jun; 39(3):1116-23. PubMed ID: 27075590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2.
    Fan C; Lin Y; Mao Y; Huang Z; Liu AY; Ma H; Yu D; Maitikabili A; Xiao H; Zhang C; Liu F; Luo Q; Ouyang G
    Oncotarget; 2016 Apr; 7(16):21825-39. PubMed ID: 26968810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of 15-PGDH causes Kras-driven tumor expansion through prostaglandin E2-ALDH1 signaling in the pancreas.
    Arima K; Ohmuraya M; Miyake K; Koiwa M; Uchihara T; Izumi D; Gao F; Yonemura A; Bu L; Okabe H; Imai K; Hashimoto D; Baba Y; Chikamoto A; Yamashita YI; Furukawa T; Araki K; Baba H; Ishimoto T
    Oncogene; 2019 Feb; 38(8):1211-1224. PubMed ID: 30250298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 15-Deoxy-Δ12,14-prostaglandin J2 induces expression of 15-hydroxyprostaglandin dehydrogenase through Elk-1 activation in human breast cancer MDA-MB-231 cells.
    Kim HR; Lee HN; Lim K; Surh YJ; Na HK
    Mutat Res; 2014 Oct; 768():6-15. PubMed ID: 25773924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 15-hydroxyprostaglandin dehydrogenase (15-PGDH) prevents lipopolysaccharide (LPS)-induced acute liver injury.
    Yao L; Chen W; Song K; Han C; Gandhi CR; Lim K; Wu T
    PLoS One; 2017; 12(4):e0176106. PubMed ID: 28423012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha.
    Otani T; Yamaguchi K; Scherl E; Du B; Tai HH; Greifer M; Petrovic L; Daikoku T; Dey SK; Subbaramaiah K; Dannenberg AJ
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G361-8. PubMed ID: 16195422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is up-regulated by flurbiprofen and other non-steroidal anti-inflammatory drugs in human colon cancer HT29 cells.
    Chi X; Freeman BM; Tong M; Zhao Y; Tai HH
    Arch Biochem Biophys; 2009 Jul; 487(2):139-45. PubMed ID: 19501039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.